Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation

PURPOSE: Both epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy are widely applied for the treatment of advanced non-small-cell lung cancer (NSCLC) with EGFR mutations, and the combination of EGFR-TKIs and chemotherapy has been used for advanced NSCLC patients;...

Full description

Saved in:
Bibliographic Details
Published in:Biologics
Main Authors: Wen, Miaomiao, Xia, Jinghua, Sun, Ying, Wang, Xuejiao, Fu, Xianghui, Zhang, Yanning, Zhang, Zhipei, Zhou, Yongan, Li, Xiaofei
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2018
Subjects:
Perspectives
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280904/
https://ncbi.nlm.nih.gov/pubmed/30555222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S169305
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items